Literature DB >> 16355870

The virulence of the 1918 pandemic influenza virus: unraveling the enigma.

J K Taubenberger1.   

Abstract

The 1918 influenza pandemic caused acute illness in 25-30% of the world's population and resulted in the death of up to 40 million people. Using lung tissue of 1918 influenza victims, the complete genomic sequence of the 1918 influenza virus is being deduced. Neither the 1918 hemagglutinin nor neuraminidase genes possess mutations known to increase tissue tropicity that account for virulence of other influenza virus strains, such as A/WSN/33 or the highly pathogenic avian influenza H5 or H7 viruses. Using reverse genetics approaches, influenza virus constructs containing the 1918 hemagglutinin and neuraminidase on an A/WSN/33 virus background were lethal in mice. The genotypic basis of this virulence has not yet been elucidated. The complete sequence of the non-structural (NS) gene segment of the 1918 virus was deduced and also tested to determine the validity of the hypothesis that enhanced virulence in 1918 could have been due to type I interferon inhibition by the NS1 protein. Results from these experiments suggest that in human cells the 1918 NS1 is a very effective interferon antagonist. Sequence analysis of the 1918 influenza virus is allowing us to test hypotheses as to the origin and virulence of this strain. This information should help elucidate how pandemic influenza virus strains emerge and what genetic features contribute to virulence in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16355870     DOI: 10.1007/3-211-29981-5_9

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  11 in total

1.  Immunodominant peptides from conserved influenza proteins--a tool for more efficient vaccination in the elderly?

Authors:  Giovanni Almanzar; Dietmar Herndler-Brandstetter; Sandra Vega Chaparro; Brigitte Jenewein; Michael Keller; Beatrix Grubeck-Loebenstein
Journal:  Wien Med Wochenschr       Date:  2007

2.  Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.

Authors:  Nayer Khazeni; David W Hutton; Alan M Garber; Douglas K Owens
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

3.  Encephalitis lethargica and the influenza virus. II. The influenza pandemic of 1918/19 and encephalitis lethargica: epidemiology and symptoms.

Authors:  Paul Bernard Foley
Journal:  J Neural Transm (Vienna)       Date:  2009-08-26       Impact factor: 3.575

4.  Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study.

Authors:  Nayer Khazeni; David W Hutton; Cassandra I F Collins; Alan M Garber; Douglas K Owens
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

5.  The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness.

Authors:  Carlos Franco-Paredes; Peter Carrasco; Jose Ignacio Santos Preciado
Journal:  J Immune Based Ther Vaccines       Date:  2009-08-07

Review 6.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

7.  Encephalitis lethargica and influenza. I. The role of the influenza virus in the influenza pandemic of 1918/1919.

Authors:  Paul Bernard Foley
Journal:  J Neural Transm (Vienna)       Date:  2008-12-10       Impact factor: 3.575

Review 8.  Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza viruses.

Authors:  Lanying Du; Ye Li; Jimin Gao; Yusen Zhou; Shibo Jiang
Journal:  Rev Med Virol       Date:  2012-09-14       Impact factor: 6.989

9.  Intense circulation of A/H5N1 and other avian influenza viruses in Cambodian live-bird markets with serological evidence of sub-clinical human infections.

Authors:  Srey Viseth Horm; Arnaud Tarantola; Sareth Rith; Sowath Ly; Juliette Gambaretti; Veasna Duong; Phalla Y; San Sorn; Davun Holl; Lotfi Allal; Wantanee Kalpravidh; Philippe Dussart; Paul F Horwood; Philippe Buchy
Journal:  Emerg Microbes Infect       Date:  2016-07-20       Impact factor: 7.163

Review 10.  Exploration of the Sialic Acid World.

Authors:  Roland Schauer; Johannis P Kamerling
Journal:  Adv Carbohydr Chem Biochem       Date:  2018-11-28       Impact factor: 12.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.